Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.47 |
| ▸ | EGLN1 | Q9GZT9 | 4/20 | 0.47 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.47 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.47 |
| ▸ | KDM5C | P41229 | 3/20 | 0.44 |
| ▸ | PHF8 | Q9UPP1 | 3/20 | 0.44 |
| ▸ | KDM2A | Q9Y2K7 | 3/20 | 0.44 |
| ▸ | KDM6B | O15054 | 2/20 | 0.44 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | SLC13A3 | Q8WWT9 | 1/20 | 0.38 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.38 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 4/20 | 0.36 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.35 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.35 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28055752 | 0.97 | LMNA (0.45) | LMNAEGLN1ALKBH5SUCNR1KDM5C | |
| Succinic Acid SCHEMBL15323172 | 0.91 | EGLN1 (0.43) | LMNAEGLN1ALKBH5SUCNR1KDM5C | |
| Butane SCHEMBL7832973 | 0.91 | FFAR3 (0.44) | LMNAEGLN1ALKBH5SUCNR1KDM5C | |
| SCHEMBL1436576 | 0.89 | TSHR (0.40) | LMNATSHR | |
| SCHEMBL27917192 | 0.85 | LMNA (0.52) | LMNASLC22A6TSHRNFKB1PMP22 | |
| SCHEMBL5045326 | 0.85 | TSHR (0.54) | LMNAEGLN1ALKBH5SUCNR1SLC22A6 | |
| SCHEMBL27887441 | 0.83 | TSHR (0.55) | LMNAOR51E2SLC22A6TSHRNFKB1 | |
| SCHEMBL27928223 | 0.83 | TSHR (0.55) | LMNAOR51E2SLC22A6TSHRNFKB1 | |
| SCHEMBL1811252 | 0.83 | TSHR (0.55) | LMNAOR51E2SLC22A6TSHRNFKB1 | |
| SCHEMBL27732791 | 0.83 | TSHR (0.55) | LMNAOR51E2SLC22A6TSHRNFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3436420-A1 | METHOD FOR HYDROGENATING CARBOXYLIC ACIDS IN ORDER TO FORM ALCOHOLS | BASF SE (DE) | 2019-02-06 | — | — | EP | claimed |
| US-20230364183-A1 | CARTILAGE-HOMING PEPTIDES | FRED HUTCHINSON CANCER CENTER | 2023-11-16 | — | — | US | disclosed |
| US-11802103-B2 | Process of making calcium alpha-ketoglutarate | PONCE DE LEON HEALTH DESIGNATED ACTIVITY COMPANY (IE) | 2023-10-31 | — | — | US | disclosed |
| US-20230211000-A1 | TISSUE-HOMING PEPTIDE CONJUGATES AND METHODS OF USE THEREOF | Blaze Bioscience, Inc. | 2023-07-06 | — | — | US | disclosed |
| US-11648290-B2 | Cartilage-homing peptides | FRED HUTCHINSON CANCER CENTER (US) | 2023-05-16 | — | — | US | disclosed |
| US-11559580-B1 | Tissue-homing peptide conjugates and methods of use thereof | Blaze Bioscience, Inc. (US) | 2023-01-24 | — | — | US | disclosed |
| US-11331393-B2 | Renal-homing peptide conjugates and methods of use thereof | Blaze Bioscience, Inc. (US) | 2022-05-17 | — | — | US | disclosed |
| US-20220016202-A1 | CARTILAGE-HOMING PEPTIDES | FRED HUTCHINSON CANCER CENTER | 2022-01-20 | — | — | US | disclosed |
| US-11090358-B2 | Cartilage-homing peptides | FRED HUTCHINSON CANCER RESEARCH CENTER (US) | 2021-08-17 | — | — | US | disclosed |
| US-20210171589-A1 | TRUNCATED CARTILAGE-HOMING PEPTIDES AND PEPTIDE COMPLEXES AND METHODS OF USE THEREOF | Blaze Bioscience, Inc. | 2021-06-10 | — | — | US | disclosed |
| EP-1228118-A1 | POLYESTER ASSOCIATION THICKENERS | Avecia Limited (GB) | 2002-08-07 | — | — | EP | disclosed |
| WO-2001030882-A1 | POLYESTER ASSOCIATION THICKENERS | AVECIA LIMITED (GB) | 2001-05-03 | — | — | WO | disclosed |
| US-6224893-B1 | WOUND HEALING AGENT | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2001-05-01 | — | — | US | disclosed |
| EP-1011633-A1 | SEMI-INTERPENETRATING OR INTERPENETRATING POLYMER NETWORKS FOR DRUG DELIVERY AND TISSUE ENGINEERING | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2000-06-28 | — | — | EP | disclosed |
| EP-0945721-A2 | Biosensitive element for surface plasmon resonance measurements, and its method of manufacture | DAI NIPPON PRINTING CO., LTD. (JP) | 1999-09-29 | — | — | EP | disclosed |
| WO-1998052543-A1 | SEMI-INTERPENETRATING OR INTERPENETRATING POLYMER NETWORKS FOR DRUG DELIVERY AND TISSUE ENGINEERING | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1998-11-26 | — | — | WO | disclosed |
| EP-0865439-A4 | COMBINATORIAL LIBRARIES HAVING AMINODIOL MONOMER SUBUNITS | ISIS PHARMACEUTICALS INC (US) | 1998-11-11 | — | — | EP | disclosed |
| EP-0865439-A1 | COMBINATORIAL LIBRARIES HAVING AMINODIOL MONOMER SUBUNITS | ISIS PHARMACEUTICALS, INC. (US) | 1998-09-23 | — | — | EP | disclosed |
| WO-1996040672-A1 | COMBINATORIAL LIBRARIES HAVING AMINODIOL MONOMER SUBUNITS | ISIS PHARMACEUTICALS, INC. (US) | 1996-12-19 | — | — | WO | disclosed |
| US-3970598-A | POLYESTER | M & T CHEMICALS INC. (US) | 1976-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11648290-B2 | Cartilage-homing peptides | CXCL12, CCL2, MATR3 | LMNA 2378/4885EGLN1 3283/4885ALKBH5 4841/4885 |
| US-20230364183-A1 | CARTILAGE-HOMING PEPTIDES | CXCL12, CCL2, MATR3 | LMNA 2378/4885EGLN1 3283/4885ALKBH5 4841/4885 |
| US-20220016202-A1 | CARTILAGE-HOMING PEPTIDES | CXCL12, CCL2, MATR3 | LMNA 2378/4885EGLN1 3283/4885ALKBH5 4841/4885 |
| US-20210171589-A1 | TRUNCATED CARTILAGE-HOMING PEPTIDES AND PEPTIDE COMPLEXES AND METHODS OF USE THEREOF | MATR3, CXCL12, UTRN | LMNA 1769/4885EGLN1 3046/4885ALKBH5 4879/4885 |
| US-11331393-B2 | Renal-homing peptide conjugates and methods of use thereof | CXCL12, ATP6V1B1, VIP | LMNA 3674/4885EGLN1 3824/4885ALKBH5 4842/4885 |
| US-20230211000-A1 | TISSUE-HOMING PEPTIDE CONJUGATES AND METHODS OF USE THEREOF | CXCL12, CCL2, CD44 | LMNA 2866/4885EGLN1 3254/4885ALKBH5 4831/4885 |
| US-11559580-B1 | Tissue-homing peptide conjugates and methods of use thereof | CXCL12, CCL2, CD44 | LMNA 2866/4885EGLN1 3254/4885ALKBH5 4831/4885 |
| US-11802103-B2 | Process of making calcium alpha-ketoglutarate | HOGA1, OGDH, GLS | LMNA 2334/4885EGLN1 211/4885ALKBH5 1309/4885 |
| US-11090358-B2 | Cartilage-homing peptides | CXCL12, CCL2, MATR3 | LMNA 2378/4885EGLN1 3283/4885ALKBH5 4841/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.